Carina Storrs

New York

Science and Health Writer at Freelance

Freelance science journalist. Words mostly about infectious disease, mental health, medical research. Curious about much more. In NYC. She/her. Human + cat mom.

Featured in: Favicon

cnn.com (+1) Favicon

medium.com Favicon

nytimes.com Favicon

nature.com Favicon

marketwatch.com Favicon

scientificamerican.com Favicon

apa.org

salon.com

popsci.com Favicon

substack.com + 78 more

Articles

Forging New Frontiers in Computer Science

2 weeks ago | buff.ly | Carina Storrs

In the first, Bhandari and Hirawat surveyed the extensive research on how AI technologies can make ancient medicine and practices such as yoga more accessible and effective. For example, AI can help uncover possible medicinal properties in plants, and when integrated into smart devices such as fitness trackers, AI can correct yoga poses. Bhandari and Hirawat also created a framework for future research and how AI can assist in finding, interpreting, and compiling data.
NCI Program on Dog-to-Human Cancer Drug Development Focus of TV Series

1 month ago | oncologynewscentral.com | Carina Storrs

When the National Institutes of Health created the Comparative Oncology Program within the National Cancer Institute (NCI) in 2003, many thought it was “crazy” to study canine cancers for insights into human cancers, recalled Chand Khanna, PhD, DVM, the program’s founding director. Two decades later, that “crazy” idea has come a long way, with important contributions to human drug development in recent years and new tools and resources for researchers, said Amy K.
AARP Advocates to Protect Social Security

1 month ago | states.aarp.org | Carina Storrs

More than 1.3 million Massachusetts residents depend on Social Security for at least a portion of their income, the majority of them age 65 or older. But as the program approaches its 90th anniversary in August, its future financial stability—and ability to fully pay out monthly benefits—is an ongoing concern. The issue has become especially pressing in recent months, with the Social Security Administration being one of the federal agencies targeted for workforce reductions and other changes.
Cancer Drugs’ Sexual Toxicity Spurs “Call to Action” for Oncologists

2 months ago | oncologynewscentral.com | Carina Storrs |Youssef Rddad

More work is needed to adequately address sexual and reproductive toxicity in patients receiving treatment for cancer, according to a comment recently published in Lancet Oncology. David J. Benjamin, MD, of the Hoag Family Cancer Institute in Newport Beach, California, and Mark P.
Oncologists’ EHR Burden Dramatically Rising: New Data

2 months ago | oncologynewscentral.com | Harsha Vyas |Rebecca Johnson |Carina Storrs |Samyukta Mullangi

An analysis of EHR metadata from 2019 to 2022 found that the number of EHR messages for oncologists grew by 19.0%, with medical oncology hit the hardest. These findings, published in JNCI: Journal of the National Cancer Institute, emphasize the need for health systems to implement approaches that help reduce oncologists’ EHR burden, experts say. “Otherwise, we’re going to lose a really valuable modality for patients and clinicians to communicate in a way they previously wouldn’t have.
Oncology Nurse Shares “Crazy Experience” on Netflix’s Love Is Blind

2 months ago | oncologynewscentral.com | Carina Storrs

Sara Carton, RN, a Minneapolis-based hematology-oncology nurse, is used to creating deep, meaningful connections with patients. She has worked in cancer care since her graduation in 2018. Although vastly different, there are parallels between her career in oncology and the emotionally charged, high-stakes environment of Netflix’s Love Is Blind. Carton, who got hooked on the reality television series during its first season in 2020, found herself drawn to it.
Fighting Back Against Fraud in Michigan

2 months ago | states.aarp.org | Carina Storrs

A man posing as a bank employee stole $40,000 in cash from an 84-year-old woman in a Detroit suburb several months ago. The case captured media attention because local police — alerted by the woman’s daughters — caught the suspect as he arrived at her doorstep to take another $25,000. It is one of many stories of fraud that regularly appear on the local TV news, says Brenda Price, an AARP Michigan associate state director for community outreach.
FDA Expands Radiopharmaceutical Indication for Advanced Prostate Cancer

2 months ago | oncologynewscentral.com | Carina Storrs |Emily Bader |Youssef Rddad

On March 28, the U.S. Food and Drug Administration (FDA) expanded the indication for lutetium Lu 177 vipivotide tetraxetan (Pluvicto) to include adults with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have undergone prior androgen receptor pathway inhibition (ARPI) therapy and can postpone taxane-based chemotherapy.
Practice Consolidation Changes Hitting Radiation Oncology Hard

Mar 27, 2025 | oncologynewscentral.com | Alexis Pellek |Alicia Ault |Carina Storrs |Youssef Rddad

Practice consolidation in radiation oncology has led to fewer and larger practices, even as the total number of physicians in the specialty has steadily grown, according to a new study. The findings, published in the International Journal of Radiation Oncology, Biology, Physics, offer a clearer assessment of what had been a moving target in cancer care, experts say. “Radiation oncology is undergoing consolidation and has been since at least 2013.
Match Day Numbers Show “Promising” Change in Radiation Oncology

Mar 24, 2025 | shorturl.at | Carina Storrs |Dionisia Quiroga |Aaron Tallent |Youssef Rddad

This year’s Match Day results show encouraging news for radiation oncology, which saw a nearly 60% drop in unfilled positions from last year, according to data published Friday by the National Resident Matching Program (NRMP). “There were just five unfilled PGY-2 positions, compared to 12 last year and 34 the year before,” noted Neha Vapiwala, MD, president-elect of the American Society for Radiation Oncology and a radiation oncologist with the University of Pennsylvania in Philadelphia.